Core One Labs Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Public

  • Stock Symbol
  • COOL

Stock Symbol

  • Investments
  • 11

  • Share Price
  • $0.10
  • (As of Thursday Closing)

Core One Labs General Information

Description

Core One Labs Inc is a psychedelic research and development life sciences enterprise focused on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy. The company intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. The Company operates a virtual clinic that assesses patients for the appropriateness of treatment plans for the use of medical cannabis to treat their symptoms. The Company partners with physicians and Health Canada's licensed producers for the provision of treatments, fulfillment of prescriptions, and sale of related products.

Contact Information

Website
www.core1labs.com
Formerly Known As
Canna Delivery System, Lifestyle Delivery Systems
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 1199 West Hastings Street
  • Suite 800
  • Vancouver, British Columbia V6E 3T5
  • Canada
+1 (888)
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Stock Exchange
CNQ
Vertical(s)
Cannabis, LOHAS & Wellness, Life Sciences
Corporate Office
  • 1199 West Hastings Street
  • Suite 800
  • Vancouver, British Columbia V6E 3T5
  • Canada
+1 (888)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Core One Labs Stock Performance

As of 01-Aug-2024, Core One Labs’s stock price is $0.10. Its current market cap is $4.95M with 47.1M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.10 $0.09 $0.07 - $0.49 $4.95M 47.1M 19.3K

Core One Labs Financials Summary

As of 30-Sep-2023, Core One Labs has a trailing 12-month revenue of $318K.

In Thousands,
USD 		TTM 30-Sep-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 13,292 18,298 7,975 49,570
Revenue 318 497 344 0
EBITDA (3,244) (12,218) (29,494) (34,942)
Net Income (3,270) (12,262) (29,543) (40,703)
Total Assets 5,578 5,969 7,469
Total Debt 188 0 24 335
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Core One Labs Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Core One Labs‘s full profile, request access.

Request a free trial

Core One Labs Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Core One Labs Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4463556-A1 Production of psychedelic compounds Pending 10-Jan-2022
DE-2757208-A1 Extn. of uranium in situ from its ores - by oxidn. and leaching with oxygen enriched water under carbon di:oxide pressure and alkaline earth (bi)carbonate soln. Inactive 28-Dec-1976

Core One Labs Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Core One Labs‘s full profile, request access.

Request a free trial

Core One Labs Acquisitions (11)

Core One Labs’s most recent deal was a Merger/Acquisition with GMP Drug for . The deal was made on 12-Jan-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
GMP Drug 12-Jan-2023 Merger/Acquisition Drug Delivery
Awakened Biosciences 10-Feb-2022 Merger/Acquisition Drug Delivery
New Path Laboratories 23-Dec-2021 Merger/Acquisition Pharmaceuticals
Akome Biotech 05-May-2021 Merger/Acquisition Biotechnology
Bluejay Mental Health Group 11-Mar-2021 Merger/Acquisition Clinics/Outpatient Services
You’re viewing 5 of 11 acquisitions. Get the full list »

Ready to get started?

Request a free trial

Core One Labs ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Core One Labs’s complete esg history, request access »

Core One Labs Exits (1)

Core One Labs’s most recent exit was on 01-Oct-2018 from CSPA Group. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
CSPA Group 01-Oct-2018 Completed
To view Core One Labs’s complete exits history, request access »

Core One Labs Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Vocan Biotechnologies Victoria, Canada 2019

Core One Labs FAQs

  • When was Core One Labs founded?

    Core One Labs was founded in 2010.

  • Where is Core One Labs headquartered?

    Core One Labs is headquartered in Vancouver, Canada.

  • What industry is Core One Labs in?

    Core One Labs’s primary industry is Drug Delivery.

  • Is Core One Labs a private or public company?

    Core One Labs is a Public company.

  • What is Core One Labs’s stock symbol?

    The ticker symbol for Core One Labs is COOL.

  • What is the current stock price of Core One Labs?

    As of 01-Aug-2024 the stock price of Core One Labs is $0.10.

  • What is the current market cap of Core One Labs?

    The current market capitalization of Core One Labs is $4.95M.

  • What is Core One Labs’s current revenue?

    The trailing twelve month revenue for Core One Labs is $318K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »